Sandra K. Loo, PhD
- Pediatric Psychology
UCLA Health Neuropsychology
|
760 Westwood Plaza, Suite C8-749, Los Angeles, CA 90095
US
About
Dr. Loo specializes in neuropsychological assessment of attention, learning, and memory within neurodevelopmental disorders, such as ADHD, Tourette Syndrome, autism and dyslexia.
Languages
Education
Residency
University of Colorado Health Sciences Center, 1999
Internship
University of Colorado Health Sciences Center, 1996
Degree
PhD, University of Hawaii at Manoa, 1996
Locations
UCLA Health Neuropsychology
Fax:310-206-8525
Hospital Affiliations
Ronald Reagan UCLA Medical Center
Medical Services
Areas of Focus
Research
Interests
- Neurocognitive and neurophysiological correlates of Attention-deficit Hyperactivity Disorder and Tourette Syndrome
- Electrophysiological biomarkers of diagnosis and treatment
- Non-medication Treatments for ADHD
Publications
Recent publications (out of 190)
- McGough, JJ, Sugar, C., Sturm, A., Salgari, G., Cowen, J., Leuchter, AF, Cook, IA. Loo, SK. (2019). Double-blind, sham-controlled, pilot study of trigeminal nerve stimulation (TNS) for attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 58(4), 403-411. doi: 10.1016.j.jaac.2018.11.013
- Loo, SK, Miyakoshi, M., Tung, K., Lloyd, E., Salgari, G., Dillon, A., Chang, S., Piacentini, J., Makeig, S. (2019). Neural activation and connectivity during cued eye blinks in chronic tic disorders. NeuroImage Clinical. 2019 July 27; 24:101956. doi.org/10.1016/j.ncil.2019.101956 [Epub ahead of print] PMID: 31382238, PMCID:PMC6698693
- Loo SK, Salgari G., Ellis A., Cowen J, Dillon A., McGough J. (2021). Trigeminal Nerve Stimulation for ADHD: Cognitive and Encephalographic Predictors of Treatment Response. Journal of the American Academy of Child and Adolescent Psychiatry, 60(7): 856-864. doi: 10.1016/j.jaac.2020.09.021. PMID: 33068751
- Michelini G, Norman LJ, Shaw P, Loo SK. (2022). Treatment Biomarkers for ADHD: Taking stockand moving forward.Transl Psychiatry. 2022 Oct 12;12(1):444. doi: 10.1038/s41398-022-02207-2. PMID: 36224169151.
- Jurgiel J., Miyakoshi M., Dillon A., Piacentini J. & Loo SK. Additive and interactive effects of attention-deficit/hyperactivity disorder and tic disorder on brain connectivity. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2023). Epub 2022 October. https://doi.org/10.1016/j.bpsc.2022.10.003. PMID: 36842882
- Michelini G, Lenartowicz A, Vera JD, Bilder RM, McGough JJ, McCracken JT, Loo SK (2023). Electrophysiological and clinical predictors of methylphenidate, guanfacine, and combined treatment effects in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2023 Apr; 62(4): 415-426. doi: 10.1016/j.jaac.2022.08.001. PMID: 35963559
- Baweja R, Faraone SV, Childress AC, Weiss MD, Loo SK, Wilens TE, Waxmonsky JG. (2024). From consensus statement to pills to pixels: New innovations in attention-deficit/hyperactivity disorder care. J Child Adolesc Psychopharmacol. 2024 Apr 30. doi: 10.1089/cap.2024.0022. Online ahead of print. PMID: 38686563
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- Medicare Advantage
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of health care plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.